Tissue-specific analysis of glycogen synthase kinase-3α (GSK-3α) in glucose metabolism: effect of strain variation.
BACKGROUND
Over-activity and elevated expression of glycogen synthase kinase-3 (GSK-3) has been implicated in the etiology of insulin resistance and Type 2 diabetes. Administration of specific GSK-3 inhibitors to diabetic or obese rodent models improves glycaemic control and insulin sensitivity. However, due to the indiscriminatory nature of these inhibitors, the relative contribution of the two isoforms of GSK-3 (GSK-3α and GSK-3β) is not known. Recently, we demonstrated that an out-bred strain of mice (ICR) lacking expression of GSK-3α in all tissues displayed improved insulin sensitivity and enhanced hepatic glucose metabolism. We also found that muscle (but not liver) inactivation of GSK-3β conferred insulin and glucose sensitization in an in-bred strain of mice (C57BL/6).


RESULTS
Here, we have employed tissue-specific deletion of GSK-3α, to examine the relative contribution of two insulin-sensitive tissues, muscle and liver, towards the insulin sensitization phenotype originally observed in the global GSK-3α KO animals. We found that mice in which GSK-3α has been inactivated in either skeletal-muscle or liver displayed no differences in glucose tolerance or insulin sensitivity compared to wild type littermates. Given the strain differences in our original analyses, we examined the insulin and glucose sensitivity of global GSK-3α KO animals bred onto a C57BL/6 background. These animals also revealed no significant differences in glucose metabolism/insulin sensitivity compared to their wild type littermates. Furthermore, deletion of hepatic GSK-3α on the out-bred, ICR background failed to reproduce the insulin sensitivity manifested by the global deletion of this isoform.


CONCLUSIONS
From these data we conclude that the improved insulin sensitivity and hepatic glucose homeostasis phenotype observed upon global inactivation of GSK-3α is strain-specific. We surmise that the insulin-sensitization observed in the out-bred strain of mice lacking GSK-3α is mediated by indirect means that do not require intrinsic function of GSK-3α in skeletal muscle and liver tissues.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Satish
S
Patel
Katrina
K
Macaulay
James R
JR
Woodgett
D000818:Animals; D005947:Glucose / Q000378:metabolism* / Q000494:pharmacology; D038362:Glycogen Synthase Kinase 3 / Q000032:analysis* / Q000172:deficiency / Q000502:physiology; D000071679:Glycogen Synthase Kinase 3 beta; D007328:Insulin / Q000494:pharmacology; D008099:Liver; D051379:Mice; D009132:Muscles; D013045:Species Specificity; D014018:Tissue Distribution
D007328:Insulin; D000071679:Glycogen Synthase Kinase 3 beta; C000605507:Gsk3b protein, mouse; D038362:Glycogen Synthase Kinase 3; C448021:glycogen synthase kinase 3 alpha; D005947:Glucose
J Clin Invest. 2004 Oct;114(7):908-16
15467829
PLoS Biol. 2008 Feb;6(2):e37
18288891
Diabetes. 2003 Mar;52(3):588-95
12606497
Diabetes. 1997 Apr;46(4):541-7
9075792
J Clin Invest. 2008 Nov;118(11):3609-18
18830417
Cell Metab. 2007 Jun;5(6):438-49
17550779
Cell Metab. 2007 Oct;6(4):329-37
17908561
Trends Mol Med. 2002 Mar;8(3):126-32
11879773
Diabetes. 2002 Jul;51(7):2190-8
12086949
Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E207-13
16478771
Cell Metab. 2005 Jan;1(1):53-61
16054044
J Clin Invest. 2006 Jul;116(7):1761-6
16823473
Nature. 2000 Jul 6;406(6791):86-90
10894547
Genesis. 2000 Feb;26(2):165-6
10686620
Anal Biochem. 1968 Oct 24;25(1):486-99
5704765
Metabolism. 1998 Jun;47(6):663-8
9627363
Expert Opin Ther Targets. 2008 Oct;12(10):1265-74
18781825
EMBO J. 1990 Aug;9(8):2431-8
2164470
J Pharmacol Exp Ther. 2006 Jan;316(1):17-24
16169938
J Clin Invest. 2004 Oct;114(7):917-27
15467830
J Biol Chem. 1999 Jan 1;274(1):305-15
9867845
Diabetes. 2002 Oct;51(10):2903-10
12351425
Nat Med. 2002 Dec;8(12):1376-82
12426561
Dev Cell. 2007 Jun;12(6):957-71
17543867
Mol Cell Biol. 2008 Oct;28(20):6314-28
18694957
J Clin Invest. 2005 Apr;115(4):940-50
15841180
EMBO J. 2005 Apr 20;24(8):1571-83
15791206